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Quantitative proteomic analysis of protein complexes: concurrent
identification of interactors and their state of phosphorylation
Abstract
Protein complexes have largely been studied by immunoaffinity purification and (mass spectrometric)
analysis. Although this approach has been widely and successfully used it is limited because it has
difficulties reliably discriminating true from false protein complex components, identifying
post-translational modifications, and detecting quantitative changes in complex composition or state of
modification of complex components. We have developed a protocol that enables us to determine, in a
single LC-MALDI-TOF/TOF analysis, the true protein constituents of a complex, to detect changes in
the complex composition, and to localize phosphorylation sites and estimate their respective
stoichiometry. The method is based on the combination of fourplex iTRAQ (isobaric tags for relative
and absolute quantification) isobaric labeling and protein phosphatase treatment of substrates. It was
evaluated on model peptides and proteins and on the complex Ccl1-Kin28-Tfb3 isolated by tandem
affinity purification from yeast cells. The two known phosphosites in Kin28 and Tfb3 could be
reproducibly shown to be fully modified. The protocol was then applied to the analysis of samples
immunopurified from Drosophila melanogaster cells expressing an epitope-tagged form of the insulin
receptor substrate homologue Chico. These experiments allowed us to identify 14-3-3epsilon,
14-3-3zeta, and the insulin receptor as specific Chico interactors. In a further experiment, we compared
the immunopurified materials obtained from tagged Chico-expressing cells that were either treated with
insulin or left unstimulated. This analysis showed that hormone stimulation increases the association of
14-3-3 proteins with Chico and modulates several phosphorylation sites of the bait, some of which are
located within predicted recognition motives of 14-3-3 proteins.
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Summary 
 
Protein complexes have largely been studied by immuno-affinity purification and (mass 
spectrometric) analysis. While this approach has been widely and successfully used it is limited 
because it has difficulties reliably discriminating true from false protein complex components, 
identifying post-translational modifications and detecting quantitative changes in complex 
composition or state of modification of complex components. We have developed a protocol 
which enables us to determine, in a single LC-MALDI-TOF/TOF analysis, the true protein 
constituents of a complex, to detect changes in the complex composition and to localize 
phosphorylation sites and estimate their respective stoichiometry. The method is based on the 
combination of four-plex iTRAQ isobaric labeling and protein phosphatase treatment of 
substrates. It was evaluated on model peptides and proteins and on the complex Ccl1-Kin28-Tfb3 
isolated by tandem affinity purification from yeast cells. The two known phosphosites in Kin28 
and Tfb3 could be reproducibly shown to be fully modified. The protocol was then applied to the 
analysis of samples immunopurified from Drosophila melanogaster cells expressing an epitope-
tagged form of the insulin receptor substrate (IRS) homologue Chico. These experiments allowed 
us to identify 14-3-3ε, 14-3-3ζ and the insulin receptor as specific Chico interactors. In a further 
experiment, we compared the immunopurified materials obtained from tagged-Chico-expressing 
cells that were either treated by insulin or left unstimulated. This analysis showed that hormone 
stimulation increases the association of 14-3-3 proteins with Chico and modulates several 
phosphorylation sites of the bait, some of which are located within predicted recognition motives 
of 14-3-3 proteins.  
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Abbreviations 
A(114): area of the iTRAQ reporter group 114 
A: angiotensin 
pA: phosphorylated angiotensin 
CIP: calf intestinal phosphatase 
IP: immunopurified sample 
IR: insulin receptor 
IRS (Chico): insulin receptor substrate 
iTRAQ: isobaric tags for relative and absolute quantification 
MALDI-TOF/TOF: Matrix-assisted laser desorption-ionization time-of-flight/time-of-flight 
SAP: shrimp alkaline phosphatase 
TAP: tandem affinity purification 
TFA: trifluoroacetic acid 
 
 
Nomenclature for phosphosites: 
A phosphorylated residue is indicated in bold font and followed by an asterisk. When the precise 
location of a phosphorylation remains ambiguous, a group of residues one of which bears the 
modification is surrounded by parentheses: AT(STS)*MNK. 
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Introduction 
 
The past few years have seen a growing interest in the characterization of protein 
complexes, the functional modules that catalyze many cellular processes. The formation of 
protein complexes and/or the modulation of their function(s) often appear to be correlated with 
the addition or removal of covalent modifications, among which phosphorylation is particularly 
important. This chemical group can indeed modulate the catalytic activity, sub-cellular 
localization and interactions of proteins and protein complexes, and is thus a key molecular 
mechanism controlling signaling pathways and other cellular functions. Methods allowing the 
detailed study of protein complexes by concurrently identifying genuine protein partners, 
detecting the variable composition of complexes upon cell stimulation, localizing 
phosphorylation sites and determining their stoichiometry would therefore likely contribute to 
understanding the molecular basis of numerous cellular processes.  
Typically, protein complexes are analyzed by mass spectrometry after affinity-
purification (1). While this approach has been successfully and widely used, it suffers from a 
number of limitations, some of which are addressed by specific methods. To distinguish true 
complex components from co-purified, non-specific interactors the composition of an 
immunopurified sample of interest has been compared to a mock-purified sample either using 
differential isotope labeling followed by quantitative mass spectrometry (MS) (2-4) or label-free 
MS approaches (5). To detect changes in the protein composition of complexes (6), as might be 
the case if complexes are isolated from cells at different states or subjected to variable 
stimulations, similar quantitative MS methods have been used (7-9). To gain insights into the 
dynamics of protein complexes in the context of signal transduction, research studies have been 
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undertaken to delineate the correlation between complex formation and reversible 
phosphorylation state of the complex components (10-12). However, in these studies, only 
relative quantification of phosphorylation was measured, without information about the 
stoichiometry of this modification within proteins. Initial attempts to overcome this limitation 
were reported in “model protein” studies in which the enzymatic digest of a sample was split into 
two halves. One fraction was de-phosphorylated using a phosphatase and the two samples were 
differentially isotopically labeled, recombined and analyzed by LC-MS/MS (13, 14). Absolute 
quantification of phosphorylation sites has been measured by comparing the MS signal of 
phosphopeptides in the sample to that of an isotopically-labeled synthetic reference peptide (15-
17). However, in this targeted approach only anticipated phosphorylation sites are quantified and 
the stoichiometry can only be determined if the absolute protein abundance is also obtained in the 
same experiment. To estimate the level of phosphorylation on a more global scale, several studies 
compared the MS signals of phosphopeptides and their non-modified counterparts, with (18) or 
without (19-22) compensation for differences in ionization and detection efficiencies. These 
methods, while individually quite successful, have failed so far to achieve the comprehensive 
analysis of protein complexes in a single analysis. 
Here we present a method to characterize protein complexes that combines the 
capabilities of some of above methods in a single analysis. It consists of the following steps. First 
an affinity-purified sample of interest and a mock-purified control sample are isolated, digested, 
the two samples are split into two halves and subjected to four-channel iTRAQ isotope labeling. 
Second, two of the four iTRAQ-labeled samples are subjected to de-phosphorylation via 
phosphatase treatment. Third, the samples are re-combined and analyzed by liquid 
chromatography – tandem mass spectrometry using a MALDI-TOF/TOF instrument, and fourth, 
the data are analyzed to distinguish true complex components from non-specific interactors and 
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to determine the site(s) and stoichiometry of phosphorylation. Therefore, the method provides the 
potential to subject immunopurified protein complexes to comprehensive analysis in a single 
experiment. The method was tested on model samples, angiotensin II and its phosphorylated 
counterpart, as well as caseins. It was also applied to the study of a complex purified from yeast 
cells by tandem affinity purification (TAP) (23), and to single-step purified complexes built 
around the Insulin Receptor Substrate, Chico, in Drosophila melanogaster cells (24). The 
procedure proved efficient in identifying bona fide interactors of Chico and variable 
phosphorylation sites regulated by insulin.  
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Material and Methods 
 Materials 
 The iTRAQ reagent multi-plex kit (reference 4352135, Applied Biosystems) contained 
the necessary reagents for resuspension (Dissolution Buffer: 500 mM triethylammonium 
bicarbonate, pH 8.5), reduction (Reducing Reagent: 50 mM tris-(2-carboxyethyl)phosphine), 
alkylation (Cysteine-Blocking Reagent: 200 mM methyl methanethiosulfonate) and differential 
labeling of protein samples. For all described samples, the protocol from Applied Biosystems 
was followed, except for adjustments of the added volumes of reducing and alkylating reagents 
which were applied depending on the initial sample volume. Modified porcine trypsin was 
purchased from Promega (reference V5113), Rapigest detergent from Waters, calf intestinal 
phosphatase (CIP) was bought from Fermentas (reference EF0341; 1 U/µL) and shrimp alkaline 
phosphatase (SAP) from Promega (reference 9PIM820; 1 U/µL). The amino-reactive bi-
functional crosslinker DSP (dithiobis[succinimidylpropionate]) was purchased from Pierce 
(reference 22585).  
 
Analysis of a peptide pair: angiotensin and its phosphorylated counterpart 
Six samples consisting of human angiotensin II (designated “A”) and Tyr-phosphorylated 
angiotensin II (designated “pA”) (references 05-23-0101 and 05-23-0111, Merck/Calbiochem, 
Darmstadt, Germany), were prepared in proportions (A/pA): (0/100), (20/80), (40/60), (60/40), 
(80/20) and (100/0), respectively. Each sample, containing a total of 600 pmol of peptide in 
water, was split in two halves which were completely dried by Speed-Vac and then resuspended 
in 3 µL of Dissolution Buffer. Two iTRAQ reagent tubes (116 and 117) were dissolved in 70 µL 
of ethanol and 11 µL of these reagent solutions were used to perform a differential labeling 
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reaction of the two halves of each mixture (A/pA). After 1h incubation on the bench, samples 
were dried by Speed-Vac and then resuspended in 20 µL of CIP buffer (Fermentas; provided with 
the enzyme: 10 mM Tris-HCl (pH 7.5 at 37°C), 10 mM MgCl2). After 30 min allowing complete 
hydrolysis of the excess of iTRAQ reagents, one unit of CIP was added to every 117-labeled 
sample. All samples (116- and 117-labeled) were incubated at 37°C for 2h30. After heating at 
85°C for 15 min to inactivate the phosphatase, samples were finally pooled by 116-117 pairs to 
reconstitute the whole (A/pA) samples. Fifteen pmol of each treated peptide pair A/pA were 
cleaned on a ZipTipC18 (Millipore), following manufacturer’s instructions to remove buffers and 
excess iTRAQ reagents. The eluates were dried by Speed-Vac and peptides were resuspended in 
50 µL of 0.1% (v/v) TFA in water. From each sample A/pA, 0.5 µL was spotted on a MALDI 
plate and mixed with 0.5 µL of matrix solution containing 4 mg/mL of α-cyano-4-
hydroxycinnamic acid (Fluka, reference 28480, >99% pure) in (ACN/water/TFA, 70/30/0.1, 
v/v/v). Samples were analyzed on a MALDI-TOF/TOF 4800 instrument (Applied Biosystems), 
by accumulating 1500 laser shots in MS analysis mode. In MS/MS analysis, 1500 shots were 
accumulated for fragmentation of angiotensin, and 4500 shots were summed for its 
phosphorylated counterpart. To test the relevance of applying a correction factor to measured 
iTRAQ ratios A(117)/A(116) and A(115)/A(114), a sample consisting of pure angiotensin (600 
pmol) and 4 µg of beta-lactoglobulin A (Sigma, reference L7880) was submitted to the previous 
protocol described above for A/pA mixtures, while using iTRAQ labels 114 and 115. 
 
 Yeast TAP sample 
 A yeast strain expressing TAP-tagged Kin28 was obtained from Open Biosystems. Cells 
were grown at 30°C until the culture reached an O.D. of 1.15. Cells were harvested and pelleted 
at 8,000 g for 10 min. Pellets were washed in (20% glycerol, 1 mM EDTA, 50 mM Tris-HCl pH 
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7.8, 150 mM KCl) and distributed into 50-mL tubes. Cells were centrifuged again at 4,000 rpm in 
a Microfuge T and the pellets (approximately 4-5 mL pellet were obtained from 3 L of culture) 
were quick-frozen in liquid nitrogen, to be stored at -80°C until use.  
Two such pellets were used for tandem affinity purification. The procedure followed was 
close to that described by Rigaut et al (25) and is detailed in Gingras et al (26). Specifically, the 
following modifications were implemented to accommodate the higher cell amount used. Five 
mL of ice-cold lysis buffer were added to each cell pellet, and cells were resuspended and 
distributed as 500-µL aliquots into 2-mL tubes. After adding 500 µL of 0.5-mm glass beads, cells 
were lysed by repeating the following cycle three times: 10 min agitation of the tubes on a 
vortexer (Vortex-Genie 2, Scientific Industries, Inc., reference SI-0276, equipped with 1.5 mL 
Snap-top Microtube Holder, reference 0A-0563-010) at maximum speed - 10 min cooling on ice. 
After discarding the cell debris by centrifugation at 13,000 rpm (Centrifuge 5415 R, Eppendorf), 
around 10 mL of protein extract (350 mg of protein, determined by Protein Assay (Bio-Rad)) 
were obtained. This lysate was pre-cleared on 400 µL of packed glutathione 4B beads 
(Amersham, reference 17-0756-01) for 2h. The extract was then incubated on 300 µL of packed 
IgG beads (Amersham, reference 17-0969-01) for 4h30. IgG beads were rinsed with 3 mL of 
lysis buffer and then three times with 3 mL of TEV buffer containing PMSF. The tagged protein 
was released by adding 600 µL of TEV buffer containing 30 µL of TEV protease (Invitrogen, 
reference 10127017). After overnight incubation on a rotating wheel at 4°C, eluted proteins were 
collected by pooling the supernatant and three washes of the IgG beads with 300 µL of 
calmodulin binding buffer (10 min incubation of the IgG beads in that buffer each time). The 
resulting 1.5 mL of protein sample was incubated with 100 µL of packed calmodulin beads (50 
µL from each manufacturer: Amersham reference 17-0529-01 and Stratagene reference 214303) 
for 3h45. After rinsing the beads, the retained proteins were eluted with 3 times 100 µL of elution 
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buffer supplemented with 0.2 mg/mL Rapigest. Each time, the 100 µL of eluting buffer were 
pipetted up and down for 1 min to thoroughly resuspend the beads and improve protein elution. 
This purified sample was heated at 95°C to denature proteins, and then split in two halves, to 
mimic two independent protein samples. The resulting samples were dried out by Speed-Vac, to 
eliminate the ammonium bicarbonate present in the final eluting buffer. Samples were sonicated 
for 10 min in 40 µL of Dissolution Buffer to help re-solubilize proteins. Both samples were 
reduced, alkylated, and digested by addition of 0.3 µg of trypsin and overnight incubation at 
37°C. Each digest was split in two halves (around 20 µL each) and the four resulting tubes were 
labelled with the four different iTRAQ reagents (114 and 115 for one digest, 116 and 117 for the 
other), resuspended in 70 µL of ethanol. After one hour reaction at ambient temperature, samples 
were concentrated to dryness and resuspended in 40 µL of CIP buffer. Tubes were further left on 
the bench for 60 min, to allow hydrolysis of excess of iTRAQ reagents. After addition of 1 M 
MgCl2 to reach a final concentration of 100 mM and thus dose the EGTA (used in the elution 
from calmodulin beads and now at around 95 mM in the four tubes), 2 µL of CIP were added in 
the 115- and 117-labelled samples. The four tubes were placed at 37°C for 3h. Then CIP was 
inactivated by heating at 85°C for 15 min; the four samples were pooled and re-digested by 
addition of 1 µg of trypsin and incubation at 37°C for 1h30. The detergent Rapigest was cleaved 
by adding a solution of 1 M HCl until reaching a pH around 2. After incubation at 37°C for 45 
min, the tube was centrifuged at 13,000 rpm for 10 min (Eppendorf Centrifuge 5415 R) to discard 
the bottom 10 µL, containing the insoluble part from Rapigest. The sample was finally cleaned by 
using consecutively three ZipTipC18, to enhance peptide recovery. 
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Analysis of standard proteins: caseins 
A sample consisting of 100 µg of beta-casein (reference C6905 from Sigma, >90% pure) 
in 50 µL of Dissolution Buffer was treated following the protocol of Figure 1, using the 
combination of CIP and SAP. The sample was supplemented with Rapigest at a final 
concentration of 0.3% (w/v) and then heated at 95°C for 5 min. After reduction and alkylation of 
the sample, 50 µL of Dissolution Buffer and 2 µg of trypsin were added to the sample before 
overnight incubation at 37°C. The obtained peptide mixture was split in two halves, which were 
labelled with iTRAQ reagents 114 and 115. The resulting samples were dried out by Speed-Vac, 
and resuspended in 100 µL of CIP buffer. Sample tubes were left on the bench for 30 min to 
allow complete hydrolysis of residual iTRAQ reagents. Then 2U of CIP and 2U of SAP were 
added to the 115-labeled sample. Both tubes were incubated at 37°C for 2h, before being heated 
at 85°C for 15 min to inactivate the phosphatases. The pooled sample was finally re-digested by 
addition of 0.8 µg of trypsin and incubation at 37°C for 2h. After cleavage of Rapigest performed 
as for the TAP sample, the sample was cleaned on Zip TipC18 and analyzed by MALDI-TOF/TOF 
MS (deposition of 350 fmol per spot), in the same conditions as the angiotensin samples. In an 
alternative experiment, casein peptides were treated with 2U of lambda phosphatase (Sigma-
Aldrich, reference P9614), using the buffer delivered with the enzyme. To finally inactivate 
phosphatase, the tubes were heated at 85°C for 30 min and supplemented with 6 mM 
orthovanadate. After pooling the two tube contents, the sample was re-digested by addition of 0.8 
µg of trypsin and incubation at 37°C for 2h. 
 
 Purification of Drosophila melanogaster protein complexes 
 Comparison sample of interest / control sample  
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 Kc167 cells were transfected with either empty pMHW-Blast (HA control) or pMHW-
chico-Blast, which allowed CuSO4-inducible expression of haemagglutinin (HA)-tagged Chico 
under control of the metallothionein (MT) promoter. Stably transfected cell pools were obtained 
by selection on 25 µg/mL blasticidin for 2 weeks. After selection cells were grown in six 175-
cm
2
 flasks, containing 32 mL of full medium (Schneider’s Drosophila medium (Invitrogen)) 
supplemented with 10% (v/v) fetal calf serum, 100 U penicillin (Invitrogen), 100 µg/mL 
streptomycin (Invitrogen) and 10 µg/mL blasticidin (Invitrogen) per flask. When a concentration 
around 5-6.10
6
 cells/mL was reached, cells were supplemented with 7 mL of fresh full medium 
per flask and with 600 µM CuSO4 for overnight induction of HA-Chico or HA-control 
expression (induction lasted typically 14h). Cell suspensions were then collected in four 500-mL 
beakers, to obtain two comparable pairs of Chico/control samples, and harvested by 
centrifugation at 1500 rpm for 5 min (using a Sorvall GS3 rotor pre-cooled at 4°C). The resulting 
pellets were washed with 40 mL of ice-cold PBS, transferred into four 50-mL tubes, and spun 
again at 400 g for 5 min. One Chico/control pair of cell pellets was quickly frozen in liquid 
nitrogen, to be stored at -80°C until use. The pair of Chico/control immunoprecipitations (IPs) 
obtained from these pellets is later called sample ‘Chico2’. The other pair of cell pellets was 
immediately processed for immuno-purification. The resulting pair of IPs is later called sample 
‘Chico1’. Cell pellets in each tube were lysed in 5 mL of lysis buffer [40 mM HEPES-KOH, pH 
7.5, 120 mM NaCl, 1 mM EDTA and 1% (v/v) Triton X-100, freshly supplemented with 1 mM 
PMSF, 50 mM NaF, 10 mM pyrophosphate, 10 mM glycerophosphate, 2 mM orthovanadate, 
EDTA-free protease inhibitor cocktail (one ‘Complete’ tablet from Roche per 20 mL of buffer) 
and 2.4 mg/mL of DSP (Dithiobis[succinimidylpropionate])]. After douncing with 10 strokes 
using a tight fitting pistil of a dounce homogenizer, the cell lysates were left on ice for 40 min. 
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DSP was used to try to increase recovery of Chico interactors by forming covalent intermolecular 
linkages. Crosslinking reaction was quenched by addition of 1.25 mL of 1 M Tris-HCl, pH 7.4, 
and incubation on ice for 30 min. Cell debris were centrifuged at 13,000 rpm for 20 min using a 
Sorvall SS-34 rotor equilibrated at 4°C. Cell extracts were then pre-cleared by incubation with 
100 µL of packed ProteinA-Sepharose (Amersham) beads for 1h on a rocker at 4ºC. Beads were 
removed by centrifugation at 800 rpm (130 g) at 4ºC (Eppendorf 5810 R). Protein concentration 
was estimated to be at 6 µg/µL in the HA-Chico lysate and 5.2 µg/µL for the control lysate (resp. 
6 and 5 µg/µL in the HA-Chico and control lysates providing sample ‘Chico2’). Lysates were 
then incubated for 3h45 in a 15-mL tube with 75 µL of packed protein-A sepharose beads packed 
with supernatant of the hybridoma cell line 12CA5, while keeping the lysates rotating at 4ºC. 
After spinning the beads at 800 rpm for 2 min (130 g), beads were washed three times with lysis 
buffer (not containing DSP) and then three times with lysis buffer containing neither detergent 
nor inhibitors (40 mM Hepes-KOH, pH 7.5, 120 mM NaCl and 1 mM EDTA). Proteins 
interacting with the beads were eluted with three times 200 µL of 2% (v/v) acetic acid in water. 
The eluates were concentrated by Speed-Vac down to 50 µL, re-diluted with 150 µL of iTRAQ 
Dissolution Buffer to reach a close to neutral pH and were supplemented with 0.1% (w/v) 
Rapigest. Samples were again concentrated by Speed-Vac down to a volume below 40 µL. Both 
protein samples were reduced, alkylated, and received additional Dissolution Buffer to reach 150 
µL. Protein digestion was performed by addition of 1.2 µg of trypsin to both samples and 
overnight incubation at 37°C. Samples were then split in two halves and concentrated by Speed-
Vac down to 30 µL. Four vials of iTRAQ reagents, 114 to 117, were resuspended in 70 µL of 
ethanol and added to the samples as follows: reagents 114 and 115 were used for the digested 
HA-Chico IP, and reagents 116 and 117 for the control IP. After one hour incubation on the 
bench, samples were dried out by Speed-Vac and resuspended in 100 µL of CIP buffer. They 
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were further left for at least 30 min on the bench to allow complete hydrolysis of the excess of 
iTRAQ reagents. Samples labelled with iTRAQ reagents 115 and 117 were then treated by 
addition of 2 U of CIP and 2 U of SAP and incubation at 37°C for 2h. The four samples were 
finally heated at 85°C for 15 min to inactivate phosphatases, and pooled to be re-digested by 1 µg 
of trypsin (1h30 - 2h incubation at 37°C). After cleavage of the detergent Rapigest, the peptide 
sample was cleaned on ZipTipC18, while using four ZipTips (twice each).  
 
Comparison of two HA-Chico IPs from cells treated or not treated with insulin 
Two independent experiments, aiming at studying the insulin-induced change in the composition 
of Chico-containing protein complexes and their state of phosphorylation, were carried out 
following the procedure of Figure 2a. The corresponding immunopurified samples +INS/noINS 
are called ‘Chico3’ and ‘Chico4’. Six flasks of HA-Chico-expressing cells were grown at 25°C in 
40 mL for sample ‘Chico3’ (resp. 45 mL for sample ‘Chico4’) of blasticidin-containing full 
medium. When they reached a concentration of 4.106 (respectively 5.106) cells per mL, overnight 
expression of HA-Chico was induced by addition of 600 µM CuSO4. Cells were harvested and 
distributed in 50-mL tubes in a manner that the content of each flask was split into two tubes, one 
of which was stimulated with insulin. Half of the tubes were treated with 100 nM bovine insulin 
(Sigma-Aldrich) for 7 min at room temperature. Cells were then pelleted by centrifugation at 400 
g for 5 min in a centrifuge pre-cooled at 4°C. Cells were washed with 40 mL of cold PBS and 
pooled to form two cell samples, treated or not treated by insulin. Cells were spun down again at 
400 g for 6 min at 4°C. They were further treated as previously described for HA-Chico/control 
cells with one exception: for preparation of sample ‘Chico4’, additional phosphatase inhibitors 
(20 nM calyculin A, 200 nM okadaic acid and 4.8 µM cypermethrin, all from Merck KGaA, 
Darmstadt, Germany) were introduced into the lysis buffer.  
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 LC-spotting for MALDI-TOF/TOF analyses 
Five or 10 µL of peptide samples were injected and loaded directly onto a C18 capillary 
column (PepMap100 C18, 75 µm i.d., 15 cm length, 3-µm particle, 100 Å porosity, Dionex) 
fitted on the injection valve of a Famos system (Dionex-LC Packings, Sunnyvale, CA, USA). 
Chromatographic separations were performed at a flow rate of 300 nL/min delivered by a 
Ultimate pump (Dionex), with a gradient from 100% A (H2O/acetonitrile/trifluoroacetic acid, 
98/2/0.1, v/v/v) to 50% B (acetonitrile/water/trifluoroacetic acid, 80/20/0.1, v/v/v) in 82 min, 
followed by 10 min flush at 100% B. The column eluate was mixed with a matrix solution 
delivered at a flow rate of 0.8 µL/min: the matrix was α-cyano-4-hydroxycinnamic acid (CHCA, 
reference 70990 from Fluka), prepared at 4 mg/mL for experiments on the MALDI-TOF/TOF 
4700 and at 2.5 mg/mL for analyses on the MALDI-TOF/TOF 4800, in 
H2O/acetonitrile/trifluoroacetic acid, 30/70/0.03, v/v/v. The resulting solution was deposited on a 
stainless steel MALDI target plate: each spot of a 192-well plate for analysis of the 4700 
instrument was formed of 20 s of column eluate; each spot of a 2000-well plate for analysis on 
the 4800 instrument was made of 10 s of eluate.  
 
MALDI-TOF/TOF analyses 
Yeast samples. MALDI plates (192-well) spotted with yeast samples were analyzed in automatic 
mode by a 4700 MALDI-TOF/TOF instrument (Applied Biosystems). Each spot was first 
analyzed in MS mode in the mass range from 750 to 4000 Da, by accumulating signal over 1500 
laser shots. Up to 15 ions giving an MS signal with S/N > 60 were then selected for further 
MS/MS analysis, performed in order of decreasing precursor signal intensity. The acquisition of 
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an MS/MS spectrum was interrupted when between 3000 shots (60 sub-spectra accumulated from 
50 laser shots each) and 5000 shots (100 sub-spectra) were accumulated. The accumulation of 
additional laser shots was halted whenever at least 4 ions with S/N above 50 were present in the 
accumulated MS/MS spectrum, in the region from 200 Da to 90% of the precursor mass. Source2 
air pressure was set to 2x10
-6
 Torr in a first and 5x10
-7
 Torr in a second MS/MS analysis. Mass 
calibration of the plate was obtained by spotting a mixture of reference peptides (des-Arg-1-
bradykinin, MH = 904.468 Da; angiotensin I, MH = 1296.685 Da; Glu1-fibrinopeptide, MH = 
1570.677 Da; ACTH(1-17), MH = 2093.087 Da; ACTH(18-39), MH = 2465.199 Da; ACTH(1-
39)) at six places around the metal plate. 
Drosophila samples. MALDI 2000-well plates spotted with Drosophila peptide samples were 
analyzed in automatic mode by a 4800 MALDI-TOF/TOF instrument (Applied Biosystems). 
Each spot was first analyzed in MS mode, by accumulating signal with up to 1000 laser shots (20 
sub-spectra of 50 shots) over the mass range 700-4000 Da; MS acquisition was stopped after 
summing 10 sub-spectra, when the accumulated spectrum contained at least 5 peaks with S/N > 
500. Up to 12 ions giving an MS signal with S/N > 40 were then candidates for further MS/MS 
analysis, performed in order of increasing precursor intensity. The acquisition of an MS/MS 
spectrum was obtained by accumulating 1500 laser shots (30 sub-spectra of 50 shots); acquisition 
was stopped after summing 20 sub-spectra, when the spectrum contained at least 4 peaks with 
S/N > 100. The source2 air pressure was set to 2.5x10
-6
 Torr for MS/MS analysis; it was 5x10
-7
 
Torr for MS analysis.  
 
Database searches of MALDI-TOF/TOF data 
Yeast samples. Acquired MS/MS spectra were interpreted using Mascot software version 2.1 
embedded in the GPS explorer software version 3.5 (Applied Biosystems). Each MS/MS 
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spectrum was processed as follows: no smoothing nor background subtraction was performed; 
only peaks of S/N ratio above 6 and of masses between 60 Da and 20 Da below the precursor 
mass were taken into account and a maximum of 65 peaks were selected to build the mass list 
representative of the MS/MS spectrum. An error tolerance on mass measurement in MS mode of 
50-75 ppm could be specified in searches; error tolerance was 0.2-0.25 Da in MS/MS mode. The 
use of trypsin was specified, and one missed cleavage was allowed. To evaluate the efficiency of 
iTRAQ labeling, searches were performed by considering this modification as partial on lysines 
and N-termini of fragmented peptides; alkylation of cysteines by MMTS was considered to be a 
complete modification. A database of yeast proteins released on the 11
th
 of August 2007 and 
containing 5812 entries (ftp://ftp.ebi.ac.uk/pub/databases/SPproteomes/fasta/proteomes/) was 
used to run searches. In the GPS explorer results, provided as supplementary XLS file, the 
following main parameters allow checking data quality: protein Mascot score, number, sequences 
and scores of peptides identifying the protein, as well as quantification data; peptides with scores 
below the Mascot threshold for reliable identifications were left aside to favour reliable peptide 
identifications and accurate protein quantification. When a peptide sequence was shared by 
multiple proteins, it was only assigned to the protein identified with the highest score. A protein 
relative abundance was calculated by averaging iTRAQ ratios measured on its proteolytic 
peptides; assuming a log-normal distribution of iTRAQ ratios measured on its peptides, we 
rejected measurements outside the interval mean ± 2 SD (p = 0.05), where SD stands for the 
estimated standard deviation.  
Drosophila samples. Acquired MS/MS spectra were interpreted using Mascot software version 
2.1.0 embedded in the GPS explorer software version 3.6 (Applied Biosystems). Each MS/MS 
spectrum was processed as follows: no smoothing nor background subtraction was performed; 
only peaks of S/N ratio above 10 and of masses between 60 Da and 50 Da below the precursor 
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mass were taken into account, a maximum of 7 peaks per 200 Da window and a maximum of 50 
peaks in total were selected to build the mass list representative of the MS/MS spectrum. Using a 
plate calibration obtained by spotting the same peptide mixture as above at eight places around 
the metal plate, a tolerance on mass measurement in MS mode of 30 ppm could usually be 
specified in searches; tolerance was 0.3-0.4 Da in MS/MS mode. The use of trypsin was 
specified, while accepting one missed cleavage. iTRAQ labeling of lysines and N-termini of 
fragmented peptides and alkylation of cysteines by MMTS were considered to be complete 
modifications. The Gene Ontology Annotation (GOA) database of Drosophila melanogaster 
proteins (from the GOA Proteomes set 17.0 released on the 24
th 
of July 2006), and containing 
15878 entries, was used to run searches. 
 
Statistical interpretation of quantitative data 
The iTRAQ area ratios were normalized in order to compensate for global area variations 
in the corresponding iTRAQ channels, since the total amount of peptides loaded in the two 
samples could be different, and the median value of all ratios f could therefore be different from 
1. Simply dividing all numerator intensities by f resets the median to 1 and guarantees that most 
peptides show no change, which is essential for the accurate calculation of the derived values 
(e.g. x values in Equation 4).  
The distribution of ratios in the sample provides information about their variability. In 
order to find out which ratios corresponded to a significant change in intensity levels, the p-value 
of each ratio was calculated. The p-value is equal to the likelihood that a value equal or higher 
than the given ratio can be obtained by chance. These p-values are calculated by fitting a log-
normal distribution to the ratio values using the Matlab software (The Mathworks Inc.) or the R 
statistical package (http://www.r-project.org/). In order to make the fit robust against outliers, i.e. 
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ratios that are significantly higher or lower than the bulk of the other ratios, the ratio values lower 
than the 10-percentile or higher than the 90-percentile were not considered. The scripts can be 
obtained from the corresponding author on request, for non-commercial use. 
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Results 
1) Principle of the method 
The protocol implemented for characterizing the state of phosphorylation of proteins 
within a sample of interest is depicted in Figure 1a. The protein sample is trypsinized and the 
resulting peptide mixture is split into two halves. The samples are then labeled with iTRAQ 
reagents 115 and 114, respectively, one sample is treated with phosphatases and the samples are 
re-combined. Non-phosphorylated peptides are unaffected by the phosphatase treatment and are 
therefore expected to provide an iTRAQ area ratio A(115)/A(114) equal to 1 during MS/MS 
analysis (Figure 1b, panel A). In contrast, a protein region originally containing a phosphosite 
will generate two peptide forms, non-modified at mass M and intact phosphorylated at mass 
M+80 Da. Here we describe in detail the case of a protein containing a single phosphosite within 
a tryptic sequence. The treatment of cases of multiply phosphorylated proteolytic peptides is 
addressed in Supplementary Data 1. A pair of phosphorylated/non-phosphorylated peptides 
possessing the same amino acid sequence provides MS/MS spectra showing iTRAQ fragment ion 
signals as represented in Figure 1b, from which the following information can be calculated. 
First, the yield of phosphatase treatment, noted y, can be determined from the iTRAQ reporter 
group areas in the MS/MS spectrum of the phosphorylated species (Figure 1b, panel B): 






−=
P
P
A
A
y
)114(
)115(
1            (1) 
The subscript P indicates that the iTRAQ reporter group areas are measured in the spectrum of a 
phosphorylated peptide.   
Second, the level of phosphorylation x of a peptide can be calculated from the yield of 
phosphatase treatment, y, and from the iTRAQ reporter group areas measured in the MS/MS 
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spectrum of the de-phosphorylated peptide form (Figure 1b, panel C), marked with the subscript 
dP: 
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where r is the ratio of iTRAQ reporter group areas: 
dP
dP
A
A
)114(
)115(
. 
When the phosphatase treatment goes to completion, equation (2) becomes: 
r
r
x
1−
=            (3) 
This expression implies that the initial peptide sample was perfectly split into two halves 
before iTRAQ labeling, so that the average A(115)/A(114) ratio calculated over non-
phosphorylated peptides is equal to 1. Due to experimental variations (e.g. variability of iTRAQ 
labeling efficiency and of quantitative measurements on the MALDI-TOF/TOF instrument), such 
peptides should provide a distribution of ratios centred on 1. The main reason why the 
distribution may be centred around a different value is the possibly inaccurate splitting of the 
digested samples into two halves before differential iTRAQ labeling 115/114. The 
experimentally obtained distribution of iTRAQ ratios A(115)/A(114) is therefore re-centred on 1 
and the corresponding correction factor is applied to all individual iTRAQ ratios to calculate 
proper estimates of phosphorylation stoichiometries. Be f this factor, Equation (2) becomes: 
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Similar equations can be written for samples labeled with iTRAQ reagents 116 and 117. 
 at SM
AC Consortium
 - University of Zürich on February 9, 2010 
w
w
w
.m
cponline.org
D
ow
nloaded from
 
  22
Finally, it has to be noted that we consider that a protein may be either non-modified or 
phosphorylated at any given S, T or Y residue; we do not take into account other possible 
modifications such as glycosylation that might also be present on these residues. Then, the 
estimated stoichiometry of phosphorylation at a given site corresponds to the phosphorylated 
fraction of the protein as compared to the fraction which is non-modified at that site. 
The strategy is extended to four iTRAQ labels to compare two independent protein 
samples, in terms of protein abundances and phosphorylation levels. A sample immunopurified 
using a tagged bait can be compared to a corresponding control sample. Alternatively, two 
samples obtained in two different conditions of interest (e.g. variable stimuli applied to cells) can 
be compared. Figure 2 schematically illustrates this extended strategy and most of the iTRAQ 
patterns which can be expected. We evaluated the possibility of comparing in detail two protein 
samples with this protocol, by testing and optimizing it on: (1) a pair of peptides which differed 
by a single site of phosphorylation, (2) a yeast protein sample isolated by tandem affinity 
purification (TAP), (3) model proteins, caseins, known to contain several phosphorylation sites 
and (4) two samples prepared by a single-step immuno-purification from Drosophila 
melanogaster cell lysates. To limit the search time we performed the database searches without 
considering possible phosphorylation sites. This is justified because in most instances 
phosphorylated species are less likely to be selected for fragmentation than non-modified ones 
due to their lower ionization efficiency, at least in MALDI analysis mode, and their fragment ion 
spectra are often more difficult to read in terms of amino acid sequence.  
 
2) Analysis of a single peptide 
The possibility to detect phosphorylated peptides and to estimate the stoichiometry of 
phosphorylation with the described method was first tested on a commercially available peptide, 
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angiotensin II, whose phosphorylated form is modified on a tyrosine. Mixtures of angiotensin 
(denominated ‘A’) and its phosphorylated counterpart (‘pA’) were prepared in different 
proportions, described as A/pA: (0/100), (20/80), (40/60), (60/40), (80/20) and (100/0), 
respectively. These samples were treated following the protocol of Figure 1a, (without the 
digestion step) using iTRAQ reagents 116 and 117, and were analyzed on a MALDI-TOF/TOF 
instrument. Peptide A was analyzed in MS/MS mode in each spotted sample, from 20/80 to 
100/0, to generate five independent spectra. Peptide pA was also fragmented once in all of the 
samples 0/100 to 80/20.  
Figures 3a and b represent the pair of MS/MS spectra obtained on peptides A and pA in 
sample 40/60. In the MS/MS spectrum of pA, the weak signal detected at 117.1 Da indicated 
efficient de-phosphorylation by the phosphatase. The yield of de-phosphorylation was estimated 
from that spectrum using Equation (1). It ranged from 0.92 to 1 for the different A/pA samples. 
The ratio r was calculated from the MS/MS spectrum of angiotensin. Pairs of values (y, r) were 
obtained for each sample, except for sample (100/0), to which y(80/20) was attributed. The 
phosphorylation level of angiotensin in the initial samples was finally estimated following 
Equation (2). The experimentally measured level of phosphorylation in the different mixtures was 
plotted against the expected level of phosphorylation in Figure 3c.  
Estimation of phosphorylation levels in each sample was characterized by a narrow 
standard deviation, indicative of good repeatability of quantitative measurements. Some 
measured phosphorylation levels slightly deviated from the expected values. The inaccurate 
preparation of mixtures A/pA and the imperfect splitting of the samples into two halves before 
differential iTRAQ labeling are the two possible sources of error, which may be additive or 
compensate each other. In the case of samples consisting of digested proteins, the second source 
of error can be corrected by dividing the ratio A(115)/A(114) or A(117)/A(116) measured on 
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each peptide by the average ratio calculated for a statistical population of non-phosphorylated 
peptides. To illustrate the relevance of this correction, a new sample A/pA = 100/0 was prepared 
by initially mixing angiotensin with beta-lactoglobulin, and performing the protocol of Figure 1a 
with iTRAQ labels 114 and 115. This sample was not affected by the first source of error 
mentioned above. The ratio A(115)/A(114) measured on angiotensin was corrected by the 
average ratio A(115)/A(114) measured on 8 tryptic peptides from beta-lactoglobulin. This 
correction brought the angiotensin ratio A(115)/A(114) from 1.17 to 1.08 and thus the estimated 
initial phosphorylation level from 14% to 7% (assuming complete de-phosphorylation). The use 
of a correction factor thus provided a better estimate of the initial phosphorylation level which 
was null in this case. 
In the next studied samples consisting of digested protein mixtures, the only source of 
error affecting the measurements of phosphorylation levels will be the inaccurate splitting of the 
digested sample before differential iTRAQ labeling. As the majority of the detected peptides is 
not phosphorylated, the quantitative data generated from those peptides is used to re-adjust the 
splitting ratio to 1:1 (see Material and methods).  
 
3) Evaluating the method on a yeast protein complex purified by TAP  
We next tested the method for the characterization of a protein complex. We attempted to 
address several questions from the same analysis. First, we asked whether an efficient iTRAQ 
labeling could be obtained on immunopurified samples. Second, because our protocol comprises 
several processing steps of the two compared samples separately, we wanted to test the resulting 
dispersion of quantitative measurements. Third, we asked in which limits our method was able to 
detect and quantify phosphorylations in target proteins.  
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These questions were addressed using the trimeric TFIIK sub-complex of the basal 
transcription factor TFIIH which has been known to be composed of the cyclin-dependent kinase 
Kin28 and its two regulatory subunits, the cyclin Ccl1 and the RNA polymerase II transcription 
factor B subunit 3, Tfb3. Our goal was not to determine additional interaction partners of the 
trimer. Rather, we chose this sample to test the method for its ability to identify and quantify sites 
of phosphorylation. Kin28 was shown to be activated by phosphorylation at T
162
 (27). Tfb3 was 
also described as phosphorylated at T
258
 (28), but to our knowledge, no information is yet 
available on the extent of this modification. The sample was prepared from cells expressing TAP-
Kin28. To estimate the reproducibility of quantitative measurements, we compared the TAP 
sample to itself: the isolated sample was split into two halves, called TAP1 and TAP2 which 
were treated following the protocol of Figure 2a, using iTRAQ labels 114 and 115, or 116 and 
117, respectively. Aliquots of one third of the resulting peptide mixture were analyzed in 
duplicate by capillary LC-MALDI-TOF/TOF and the following data interpretation was carried 
out.  
 
Efficiency of iTRAQ labeling. The presence of partially iTRAQ modified peptides might 
complicate the quantitative conclusions drawn from the data. The acquired MS/MS spectra were 
therefore searched while allowing partial iTRAQ modification at N-termini and lysine residues. 
From the two MALDI-TOF/TOF analyses, 432 and 531 peptides, respectively, were identified by 
significant Mascot scores (p<0.05; threshold score 26). Among these, less than 3% appeared to 
be partially or non-iTRAQ labeled. Later MS/MS data were therefore interpreted assuming that 
complete iTRAQ labeling at both peptide N-termini and lysine residues had been achieved.  
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Sequence coverage of proteins. The two analyses of the TAP sample identified 64 and 75 
proteins, respectively, based on at least two peptides with Mascot scores above the significance 
threshold. Most of the proteins identified in addition to the trimer Kin28-Ccl1-Tfb3 
(predominantly ribosomal and heat shock proteins) could be repeatedly detected in TAP samples 
isolated from yeast using different bait proteins and the same protocol as in the present work 
(26), and were thus assumed to represent non-specific background proteins. They are listed in the 
Supplementary XLS file. The sequence coverage of Kin28, Ccl1 and Tfb3 with validated peptide 
identifications (scores above the significance threshold and spectra allowing reading a three-
amino-acid sequence tag or more) was 51%, 51% and 63% when the data acquired in both 
analyses were pooled (see Figure S1). In comparison, the highest-score and therefore presumably 
among the most abundant background proteins identified was the heat shock protein SSB1, with 
sequence coverage of 49% (MW 69.9 kDa) in the first analysis. These figures demonstrate that it 
is possible to reach significant sequence coverage of proteins of interest, in spite of the presence 
of numerous and possibly abundant contaminants. An important prerequisite for characterizing 
post-translational modifications of target proteins was therefore fulfilled.  
 
Relative quantification of proteins.  
The relative abundance of a protein in two samples compared with the protocol of Figure 
2a is calculated by averaging the ratios [A(116)+A(117)]/[A(114)+A(115)] for the peptides 
arising from the protein in question. As shown above, many of the identified proteins are non-
specific contaminants when two immunopurified samples are being compared. For these, 
abundance ratios close to 1 should be detected as they are expected to be present in equal 
amounts in the sample of interest and the control. For a protein to be regarded as enriched in 
either sample, it needs to appear as an outlier from the main distribution of protein ratios centered 
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on 1. It is therefore important for assessing the significance of an enrichment factor to define this 
distribution. It is characterized by the variance σtotal
2
 = σIP
2
 + σmethod
2
, the sum of the variances 
related to the immuno-purification and to the analytical method. The first variance may depend 
on the two compared cell lysates and on the beads used for immuno-purification. The second was 
estimated on our TAP sample. To determine the protein relative abundance TAP2/TAP1, the 
ratios [A(116)+A(117)]/[A(114)+A(115)] measured on all identified peptides were grouped per 
protein and averaged. When considering the 51 proteins identified with at least three peptides, an 
average ratio of 1.16 ± 0.15 (SD) was calculated. Such a dispersion is close to that obtained while 
performing the classical iTRAQ procedure which consists of the comparison of up to four 
digested protein samples (29). In spite of the extra manipulation steps required to analyze 
immunoprecipitated samples, the procedure therefore provides accurate relative quantification of 
proteins. 
 
Detection of sites of phosphorylation. To identify sites of phosphorylation, the number of 
identified peptides measured at a specific iTRAQ ratio was plotted as a function of iTRAQ ratios 
A(115)/A(114) and A(117)/A(116). Plots obtained in the first LC-MALDI-TOF/TOF analysis of 
the Kin28 complex are shown in Figure 4 after correction for inaccurate splitting of the peptide 
samples. The population of non-phosphorylated peptides provides a distribution of iTRAQ ratios 
centered on 1 (or 0 in log scale) that is characterized by a certain standard deviation. This 
dispersion of measurements limits the minimum detectable level of phosphorylation: an initially 
phosphorylated peptide is detected as a de-phosphorylated species when the latter gives an 
iTRAQ ratio appearing as an outlier from the main distribution. In this case a ratio 
A(115)/A(114) and A(117)/A(116) (corrected for inaccurate peptide sample splitting) above 1.22 
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was indicative of the possible presence of a phosphorylation (p = 0.01). This threshold value 
corresponds to a phosphorylation level around 18% when y = 1, and 29% when y = 0.5. 
All peptides but one showed iTRAQ ratios belonging to the main distribution centered on 
1. The observed outlier measurements, r(115/114) = 3.14 and r(117/116) = 2.19, represent peptide 
AIPAPHEILTSNVVTR from Kin28, which contains the known phospho-threonine T
162
. The 
MS/MS spectrum acquired in spot 99 during the automated analysis of the plate is shown in 
Figure S2a. Phosphorylated peptide AIPAPHEILT*SNVVTR was automatically fragmented in 
spot 98, indicating that it eluted very closely to its non-modified form. The acquired MS/MS 
spectrum had a sufficient number of fragment ions to localize the phosphosite to residue T
162
 
(Figure S2b). In addition, the phosphorylation level was estimated to be 91% and 86% from the 
samples labeled with reagents 115-114 and 117-116, respectively. In the second LC-MALDI-
TOF/TOF analysis of this same sample, the phosphorylation level was calculated to be 96% and 
100%, respectively. In conclusion, from these two analyses, peptide AIPAPHEILT*SNVVTR 
could be considered to be completely or near completely modified at T
162
 in Kin28.  
Tfb3 was also expected to be phosphorylated, specifically at T
258
 within the sequence 
LKDAVPFTPFNGDR. This peptide was not identified by the initial database search, but closer 
examination of the MS/MS data identified the peptide in its deamidated form (N⇒D). This 
modification is commonly observed with Asn-Gly sequences (30). The fragment ion spectra of 
the non-modified and corresponding phosphorylated peptides are shown in Figure 5. The 
acquisition of an MS/MS spectrum of the phosphopeptide allowed localization of the 
modification site. The initial phosphorylation level of LKDAVPFT*PFNGDR could be 
determined to be 98% and 100%, from the samples labeled with reagents 115-114 and 117-116, 
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respectively. The same estimations were provided by both LC-MALDI-TOF/TOF analyses 
(Table 1). Again, we could conclude that Tfb3 was fully modified at T
258
.  
In spite of several sources of variability in our multi-step procedure (trypsin digestion, 
phosphatase treatment and MS acquisitions), the level of phosphorylation of Kin28 and Tfb3 
could be reproducibly determined to be between 86% and 100%, leading to the conclusion that 
both sites are completely or near completely modified in the proteins. Kin28 had already been 
shown to exist mostly in a phosphorylated form at T
162
 (31) and this phosphorylation event 
proved critical for its association with Ccl1 within the TFIIH complex (32). In contrast, we did 
not find any information on the extent of phosphorylation of T
258
 in Tfb3. We thus demonstrated 
that the method could quite reproducibly determine the phosphorylation stoichiometry on 
partially purified protein complexes, and estimated the minimum detectable level of 
phosphorylation at about 20%. 
 
4) Improving the method on model phosphoproteins: casein 
Even though Kin28 and Tfb3 could be shown to be fully modified at T
162
 and T
258
, 
respectively, de-phosphorylation of Kin28 was only effective to about 20-30%, a yield that would 
make the detection of low-level phosphorylation sites difficult. The calf intestinal phosphatase 
(CIP) has already been described to only partially de-phosphorylate some peptide sequences (33). 
To improve the level of phosphatase-catalyzed de-phosphorylation, we considered using a 
combination of several phosphatases, CIP, shrimp alkaline phosphatase (SAP) and lambda 
phosphatase. It can indeed be assumed that different phosphatases are somewhat selective for 
specific substrates, and therefore it is generally advisable to use a cocktail of these enzymes. CIP 
and SAP both require Mg
2+
 cations whereas lambda phosphatase is active with Mn
2+
 cations and 
inhibited by Mg
2+
 (34) which precludes the combined use of all three enzymes. Yet, the 
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combination of CIP and SAP could be expected to provide better de-phosphorylation of a 
statistical sample than CIP alone. Both phosphatase conditions were tested on a beta-casein 
sample which also contained minor amounts of alpha-S1-, alpha-S2- and kappa caseins, 
following the protocol of Figure 1a. The resulting sample was deposited as a single MALDI 
spot. Automated analysis of the most intense ions allowed identification of 11 non-modified 
peptides from caseins. Their average ratio r was 1.11 ± 0.19 for the sample treated by CIP and 
SAP, versus 1.08 ± 0.09 for the lambda phosphatase-treated sample. Expected tryptic 
phosphopeptides were also fragmented in their non-modified form, independently of their 
detection in MS mode. Some fragmented efficiently enough to be conclusively identified, others 
mainly produced intense iTRAQ reporter ions. In both cases, the ratio r was measured and 
corrected for inaccurate sample splitting using the average r value determined above on non-
modified species. Because the MS/MS spectra of the phosphorylated peptides usually could not 
be obtained (especially when dealing with multiply modified peptides), the initial levels of 
phosphorylation were calculated while considering a complete de-phosphorylation by 
phosphatases (y = 1). The calculated phosphorylation levels are presented in Table 2: the 
considered peptide sequences globally appeared to be minimally ¾ phosphorylated in the original 
proteins. Thus, in spite of probable over-estimation of de-phosphorylation yield, the estimation of 
phosphorylation levels was usually under-estimated by less than 25%. Since similar estimations 
of phosphorylation levels were obtained using either CIP+SAP or lambda phosphatase, both 
enzyme conditions may be considered for performing the procedure. For a given sample of 
interest, both phosphatase conditions may be tested to select the one providing the more efficient 
de-phosphorylation. We chose the combination CIP+SAP for the next experiments.  
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5) Analysis of protein complexes immunopurified from Drosophila cells.  
The optimized protocol was then applied to the analysis of immunopurified complexes 
containing the bait protein Chico (the Drosophila IRS homologue) to determine bona fide protein 
partners of Chico and insulin-induced changes in the complex composition and state of 
phosphorylation. 
In a first set of experiments, protein samples were immunopurified from Kc167 cells 
expressing either HA-tagged Chico or the HA-tag alone (control cells). The thus obtained 
samples were treated according to the protocol of Figure 2a. The whole procedure was carried out 
on two independently prepared pairs of Chico/control IPs, providing samples designated as 
‘Chico1’ and ‘Chico2’, respectively. Our goal was to determine bona fide protein partners of 
Chico, and to detect possible phosphorylation sites on the proteins of interest.  
One third of samples Chico1 and Chico2 was analyzed by LC-MALDI-TOF/TOF, 
resulting in the identification of 265 and 180 peptides, respectively. Peptide identifications were 
grouped per protein and average ratios [A(116)+A(117)]/[A(114)+A(115)] were calculated, to 
point to proteins enriched in the sample of interest. The initial protein ratios were corrected by 
considering the relative protein concentrations measured in the total lysates Chico/control. Eighty 
seven and 46 proteins were identified, respectively, from samples Chico1 and Chico2. Table 3 
lists proteins identified on the basis of at least 3 peptides. The distributions of relative protein 
abundances were plotted for both samples, as described at the end of the Material and Methods 
section (Figure S3). In both samples, 14-3-3ε, 14-3-3ζ and the insulin receptor (IR) provide 
control/Chico abundance ratios indicating they are likely interactors of Chico. Figure S4 shows 
an MS/MS spectrum identifying a peptide from 14-3-3ζ, and featuring the characteristic iTRAQ 
group pattern of a protein over-represented in Sample 1. The other proteins identified with at 
least three peptides, whose quantification was therefore reliable, were associated to ratios 
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spanning over the ranges [0.48; 1.78] in Chico1 and [0.38; 1.45] in Chico2. Given the thresholds 
indicative of protein enrichment calculated to be 0.36 and 0.27 for samples Chico1 and Chico2 (p 
= 0.01), respectively, all of these proteins appeared as contaminants.  
We next analyzed the obtained iTRAQ data for the presence of phosphorylated species by 
plotting the number of identified peptides per iTRAQ ratio A(115)/A(114). The data are shown in 
Figure S5 for samples Chico1 and Chico2. We focused on the peptides with corrected ratios r 
above 1.37 or 1.39 (for Chico1 and Chico2, respectively) as a threshold indicative of the 
detection of a phosphopeptide in its de-modified form (p = 0.01). These peptides were 
fragmented again, to confirm or invalidate their outlier ratio. Two tryptic peptides of Chico, 
LVHSISSEDYTQIK and STSAPLLSLK, repeatedly provided ratios r emerging from (for sample 
Chico2), or in the upper shoulder of (for sample Chico1) the main ratio distribution (Table 4). 
The corresponding intact phosphorylated species were then searched for and fragmented, which 
allowed us to determine the yield of phosphatase treatment on these two sequences. The MS/MS 
spectra acquired on the two pairs of peptides are given in Figures 6 and S6. From these data we 
could conclude that both sequences were approximately one-third phosphorylated in sample 
Chico1, and one-half phosphorylated in sample Chico2 (Table 4).  
 
In a second set of experiments, protein samples were immunopurified from HA-Chico-
expressing cells that were either stimulated with insulin (+INS) or not stimulated (noINS). The 
objective of these experiments was to detect possible variations in protein partners of Chico, as 
well as phosphorylation sites potentially affected by the hormone. Two obtained pairs of IPs were 
treated following the procedure of Figure 2a, to provide two independent samples designated as 
Chico3 and Chico4. One third of each sample was analyzed by LC-MALDI-TOF/TOF, and led to 
the identification of 198 and 210 peptides, respectively. Peptide identifications were grouped per 
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protein and average ratios [A(116)+A(117)]/[A(114)+A(115)] = noINS/+INS were calculated, to 
identify proteins differentially present in the two IPs. This time, protein ratios were normalized 
by adjusting to 1 the ratio measured for Chico. Results are grouped in Table 6. For proteins 14-3-
3ε and 14-3-3ζ, the ratio noINS/+INS appeared to be around 0.45 in sample Chico3, and around 
0.87 in sample Chico4, indicating increased association of Chico with 14-3-3ε and ζ in insulin-
treated cells (p = 0.01). This is visualized on the plots of protein relative abundance obtained with 
both samples, where the two partners of Chico are associated with lower noINS/+INS ratios 
(Figure S7). This trend was also visible on the silver-stained gel obtained from an aliquot of the 
samples (Figure S8). A ratio of 0.76 and 0.80 was measured in samples Chico3 and Chico4 for 
IR: the receptor would also appear to be more abundantly associated with Chico upon insulin 
stimulation (this was only statistically significant for Chico4 at p = 0.01).  
To identify phosphorylated peptides the abundance of which was insulin-dependent, 
phosphorylated species were sought by plotting the number of identified peptides per iTRAQ 
ratio as a function of iTRAQ ratios A(115)/A(114) and A(117)/A(116). The resulting plots are 
given in Figure S9. Twelve peptides emerged from the main distributions, in one cell stimulation 
condition or in both. The presumed corresponding phosphorylated peptides were looked for at 
close elution times on the already analyzed MALDI plate. In all cases, singly phosphorylated 
species showing the expected iTRAQ pattern A(114)>>A(115) and/or A(116)>>A(117) could be 
fragmented. We also tried to fragment the hypothetical doubly phosphorylated species in MALDI 
spots neighbouring the one that contained the singly phosphorylated peptides, but did not detect 
fragments in any case. We then concluded that the peptides of interest were only singly 
phosphorylated. All MS/MS spectra acquired on the pairs of non-modified / phosphorylated 
peptides are grouped at the end of Supplementary Figures and results of peptide identifications 
and iTRAQ ratios are presented in Table 5. Some phosphorylation sites were induced by insulin 
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stimulation, some were unaffected, while a third group appeared to be reduced. They are 
positioned and color-coded in the sequence of the protein (Figure 7). Interestingly, four 
automatically identified phosphorylated peptides overlap with predicted 14-3-3 recognition 
sequences (Table 5). The tryptic peptide overlapping with the fifth predicted recognition motif, 
AYSVGSK, was searched for and successfully fragmented in a non-modified form. For some of 
these peptides, the level of phosphorylation increased upon insulin stimulation (for example 
STS*APLLSLK) or was induced by the hormone (CDS*LPTR). This seems to correlate well 
with an augmented interaction of 14-3-3 proteins with Chico in stimulated cells. In conclusion, 
we could detect phosphorylation sites in Chico and measure variations of their stoichiometry 
upon insulin stimulation, which correlated with an increased association of the two 14-3-3 
proteins with the bait.  
 
 
Discussion 
We have developed a method which provides detailed characterization of protein 
complexes partially purified from total cell lysates. In the same LC-MALDI-TOF/TOF analysis 
the procedure distinguishes true complex components from non-specific interactors, measures 
changes of complex composition, points to phosphorylation sites and gives an estimation of the 
stoichiometry of phosphorylation in the sample proteins. Applied to the complex around the D. 
melanogaster protein Chico, the method reproducibly identified its interaction partners and 
estimated their levels of phosphorylation. To our knowledge, this is the first method that provides 
such detailed information by the direct LC-MS/MS analysis of whole proteolytic digests of 
partially purified protein complexes. Analysis of all peptides, modified or not, provides more 
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reliable identification of proteins and quantification of their relative abundance between 
compared samples. In the present work, identification of phosphorylation sites relies on the 
detection of the corresponding tryptic peptides in their non-modified form and therefore 
circumvents issues related to their lower ionization efficiency and lower fragmentation yield 
compared to their non-phosphorylated counterparts (10, 17, (35). Presumed intact phospho-
species can then be searched by targeted analysis of the same MALDI plate which has already 
been analyzed in automated mode, assuming that both peptides closely elute from the 
chromatographic column. Therefore, as both spectra share fragment ions of major intensity (36, 
37) the interpretation of MS/MS spectra of phosphopeptides is strongly supported by the MS/MS 
data acquired on their non-modified counterparts. It is finally worth mentioning that the splitting 
of the peptide samples into two halves, one half to be treated with phosphatases, does not reduce 
sensitivity of MS analysis, thanks to the use of the isobaric iTRAQ labels. This is in contrast to 
previous protocols also dephosphorylating half of the studied peptide sample and using labels 
differing in mass (10, 13, 14).  
 
Analytical issues 
Our method allows identifying proteins constitutive of a complex without being limited 
by a practical maximum number of components. The only critical parameter to identify a protein 
as a real partner of the bait is its enrichment level in the sample of interest versus the control 
sample. The main point is that a distribution of non-enriched peptides can be clearly defined, 
from which the enriched peptides statistically emerge. The main distribution of non-enriched 
species is more solid when the number of background proteins is much higher than that of the 
complex constituents; this is usually the case in immuno-purified samples. The fraction of 
enriched peptides may become structured in distinct sub-distributions, possibly indicative of 
 at SM
AC Consortium
 - University of Zürich on February 9, 2010 
w
w
w
.m
cponline.org
D
ow
nloaded from
 
  36
variably tight interactions with the bait (2). This is not detrimental to identifying the 
corresponding proteins as real complex constituents as long as the main distribution of non-
enriched peptides can be clearly defined. In addition, one prerequisite to identify a protein as a 
constituent of a complex is to detect it in a possibly large set of background proteins. Automated 
MALDI-TOF/TOF analysis globally leads to the identification of the more abundant proteins in 
the samples. Some real protein partners of the bait may not be identified if none of their 
proteolytic peptides provides sufficient signal in MS mode to be selected for fragmentation. As a 
global trend, a more comprehensive characterization of a protein complex will be obtained, 
whatever its complexity, if the proteins of interest represent higher abundance components of the 
analyzed sample. In our experiments, the pre-clearing steps of the cell lysates before immuno-
affinity must have helped reduce the number and amount of background proteins.  
 
Accurate quantification requires producing intense iTRAQ reporter groups. This can be 
modulated by the collision cell pressure in the MALDI-TOF/TOF instrument, which influences 
the fragmentation efficiency of peptides. The two LC-MS/MS analyses of the TAP sample were 
carried out at a gas pressure of 2x10
-6
 Torr and 5x10
-7
 Torr, respectively, in the collision cell. The 
first analysis provided much more intense iTRAQ reporter groups than the second: the sum of the 
four iTRAQ group areas averaged per identified peptide reached 95,500 for the first analysis 
versus 42,900 for the second. Quantitative measurements were therefore more reliable in the first 
analysis. This is also apparent when the number of identified peptides per iTRAQ ratio is plotted: 
the distribution width (i.e. the standard deviation characterizing the population of peptides 
theoretically associated to a ratio equal to one) is significantly lower in the first MS analysis. In 
other words, the minimum iTRAQ ratio r(115/114) or r(117/116) that significantly indicates 
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phosphorylation can be lower when using the higher collision cell pressure. For subsequent 
analyses, including those of the Chico samples, we used the higher gas pressure.  
In addition, measurements of relative protein abundance by our method may also be 
distorted by the presence of differentially phosphorylated peptides, due to the impact of 
phosphatase on the iTRAQ areas. Nevertheless, as discussed in Supplementary data 2, the impact 
of the several phosphorylations detected in Chico appeared minimal.  
 
Peptides phosphorylated on S, T or Y residues, respectively, were identified in this study. 
It is worth mentioning that we successfully quantified phosphorylation on pTyr in angiotensin. 
Indeed, the reaction of tyrosine residues with N-hydroxysuccinimide groups (contained in the 
structure of the iTRAQ labels) has been documented (38) and the occurrence of this side reaction 
in the experiments described here would have been detrimental to the correct estimation of 
phosphorylation stoichiometries on this residue. To eliminate this unwanted reaction product 
between tyrosines and N-hydroxysuccinimide groups, Munchbach et al described a final 
treatment of the sample with 0.5 M hydroxylamine. In our protocol, even though partial double 
iTRAQ labeling of angiotensin (at its N-terminus and its tyrosine) could be observed after the 
labeling step, only the singly modified (at the N-terminus) peptide form could be detected in the 
final samples A/pA. The heating step at 85°C performed in the CIP buffer (of basic pH) to 
inactivate phosphatases removed the iTRAQ label from the tyrosine.  
Our method proved successful in characterizing in detail singly phosphorylated peptides, 
by providing localization of phosphosites and estimation of their stoichiometries. The study of 
multiply phosphorylated peptides appears more difficult: determining the number of 
phosphorylation sites present on a peptide requires detecting it in its fully modified form, 
whereas the analysis by MALDI-MS of multiply phosphorylated peptides usually requires the use 
 at SM
AC Consortium
 - University of Zürich on February 9, 2010 
w
w
w
.m
cponline.org
D
ow
nloaded from
 
  38
of specific matrices (39) or additives (40, 41), to favour their ionization within the MALDI spot 
containing a large majority of non-modified peptides. The analysis of IMAC-enriched 
phosphopeptides recently published by Munton et al illustrated well the small number of multiply 
phosphorylated peptides that may be identified by automated LC-MALDI-TOF/TOF analysis of 
spots prepared in chca matrix: only 0.4% of all identified phosphopeptides were doubly 
phosphorylated, and no triply or more phosphorylated species could be reliably identified (17). 
Nevertheless, our strategy allows pointing to multiply phosphorylated peptides through detection 
of their de-phosphorylated counterparts. This was practically shown by the study of casein for 
which the de-phosphorylated forms of three initially tetra-phosphorylated peptides were 
identified. In all instances, we could conclude that the sequences were fully modified in the initial 
proteins, yet without being able to determine the number and locations of phosphorylation sites. 
To characterize these peptides further, we considered that de-phosphorylation by phosphatases 
may not have been 100% at all sites, and looked for signals corresponding to residual singly 
phosphorylated species (still phosphorylated at one of the four phosphosites). From ionic species 
probably corresponding to (NANEEEYSIGSSSEESAEVATEEVK)* and 
(ELEELNVPGEIVESLSSSEESITR)* we could obtain MS/MS spectra containing no signal for 
iTRAQ group 114 (data not shown), as this is expected for initially multiply phosphorylated 
peptides (see Supplementary data for more detailed explanations); we could then conclude that 
these two peptides were at least doubly phosphorylated in the original protein. However, 
fragmentation was not efficient enough to allow reading sequence information and localize any 
phosphosite. In terms of quantification, estimating the stoichiometry of phosphorylation sites in 
multiply and heterogeneously phosphorylated peptides (modification level x1 at site Res1, x2 at 
site Res2, etc) requires approximations, as explained in Case 2 of the Supplementary text. 
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The proteins analyzed in this study, the trimer Kin28-Ccl1 and Tfb3, as well as Chico and 
the 14-3-3 proteins were identified with above 50% sequence coverage. To extend the 
characterization of phosphorylation sites, increased coverage could be obtained by repeated LC-
MS/MS analyses, by targeted MS/MS analysis of theoretical masses of their tryptic peptides and 
by utilizing a protease different from trypsin. The presented procedure is also consistent with 
ESI-MS/MS instruments capable of detecting low-mass iTRAQ reporter groups. Since they 
globally favor ionization of different sets of peptides, the two ionization methods are expected to 
provide complementary sets of data (42). Compared to MALDI, electrospray is likely to favor 
ionization of phospho-species, in particular multiply phosphorylated peptides, and thus may 
allow better characterization of multiply and heterogeneously phosphorylated species. But 
targeted fragmentation of peptides of interest in LC-ESI-MS/MS has the drawback of requiring 
injecting new peptidic material whereas on a MALDI platform the original sample can be re-
investigated.  
Phosphopeptides may escape identification for two other reasons. First, a non-modified 
peptide emerges as a candidate for being phosphorylated in the intact proteins, on condition that 
the yield of phosphatase treatment is sufficiently high to bring the ratio r = A(115)/A(114) (or 
A(117)/116)) above a certain threshold. We estimated on the TAP sample that in the optimal case 
of complete de-phosphorylation by phosphatase, a minimum level of 20% phosphorylation could 
be detected. Second, the presence of a phosphorylation site in the close proximity to a trypsin 
cleavage site can hamper proteolysis at that site resulting in the complicated scheme depicted in 
Figure S10. In an attempt to find additional phosphopeptides that may have been fragmented in 
the automated analysis of the plate, we performed a second round of database searches on 
samples Chico3 and Chico4, while considering potential phosphorylations on S, T and Y 
residues. This led to the identification of one additional phosphorylated sequence, which actually 
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corresponded to the second above mentioned issue: peptide GSRES*PPVSACPEDGNTYAK 
was identified in sample Chico4 (Mascot score 34). However, as detailed in Supplementary data 
3, no estimation of its stoichiometry of phosphorylation could be obtained due to the missed 
trypsin cleavage. Based on these considerations, we suggest a two-step interpretation of MS/MS 
data obtained with the procedure. First, a database search performed without considering 
phosphorylation allows rapid and reliable identification of non-modified peptides, and points to 
the existence of phosphorylated counterparts. Second, to handle the issues of insufficient de-
phosphorylation of some sequences and inhibited trypsin cleavage, the data can be re-searched, 
this time taking into account possible phosphorylation. Finally, when seeking presumed 
phosphopeptides, if no fragmentation spectrum can be obtained at a mass 80 Da above that of the 
non-modified peptide, sequences resulting from a missed cleavage should be looked for.  
Following this procedure, 12 distinct sequences of Chico were proved to be 
phosphorylated, with accurate estimation of the modification stoichiometry down to ~ 40% (see 
Table 5). Similar results should be generally attainable with immunopurified samples. 
 
Biological relevance of the results 
The two 14-3-3 proteins ε and ζ were identified as interactors of Chico and their 
association appeared to increase upon insulin stimulation of cells. The mammalian homologues 
of Chico, IRS-1 (43), as well as IRS-2 and IRS-4 (44), were also shown to bind to 14-3-3 
proteins. IRS-1 was proven to interact with 14-3-3β in 3T3L1 adipocytes, and this binding was 
shown to increase with insulin treatment (45, 46). In contrast, Ogihara et al. did not observe a 
significant change of interaction between 14-3-3ε and IRS-1 upon hormonal stimulation in 
HepG2 cells (43); nevertheless, this observation relied on western blotting, which provides less 
accurate quantitative data than MS-based approaches and may not have been able to detect 
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changes at or below 2-fold, such as those observed here using mass spectrometry techniques. In 
NIH-3T3 cells, 14-3-3ε was shown to interact with IRS-1 and PKC-α, thus modulating insulin 
signaling and degradation (47). We have also observed an increased association of Chico and IR 
after a 7-min insulin treatment, which reflects activation of the insulin pathway involving 
tyrosine-phosphorylation of Chico by IR: in samples Chico3 and Chico4, the abundance ratio 
noINS/+INS for the receptor was 0.76 and 0.80.  
We stimulated Kc cells with an insulin concentration and within a time window 
previously established to give a robust induction of the whole pathway ((48) and our own 
experience). As a result, we identified several insulin-dependent phospho-sites, mainly phospho-
serines, in Chico. The roles of phospho-serines/threonines in the mammalian homologue IRS-1 
have been studied with regard to the regulation of the insulin pathway. Some serine residues, 
when phosphorylated, participate in the negative control of insulin signaling (49-51), while others 
appear to have a positive regulatory function (52, 53). The homology of the Chico sequence to 
the mammalian IRS homologues is too weak to allow precise comparison of phospho-sites. 
Nonetheless, it is worth mentioning that some serine residues were previously shown to become 
partially or fully phosphorylated in rat and mouse IRS-1 after 5 min stimulation with 80-100 nM 
insulin (52, 54), which was in agreement with our observations. Among the phosphorylated 
residues identified in Chico, several appear to correlate with insulin stimulation, either positively 
or negatively. Most interestingly, five sequences overlap with predicted recognition motives of 
14-3-3 proteins. All but one of them were shown to become more highly phosphorylated upon 
stimulation which correlates well with an enhanced association of the two 14-3-3 proteins with 
Chico. The differences of phosphorylation levels measured in samples Chico3 and Chico4 may 
be, at least in part, due to the different cell densities reached before induction. In spite of 
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differences in absolute phosphorylation levels, similar variations of the phosphorylation states 
(increase or decrease) are observed in the two samples upon insulin stimulation. 
Phosphorylations on tyrosine residues were also expected, at least upon insulin treatment 
(55). As described in Supplementary data 4, the presence of phospho-tyrosine-containing 
peptides could not be conclusively established by our MS data. Nonetheless, the intact protein 
Chico could be shown to contain phosphorylated tyrosines: a fraction of the samples Chico3 and 
Chico4 was analyzed by Western Blot using an anti-phosphotyrosine antibody, and signal was 
detected in both insulin conditions, with increased signal in the +INS case, as expected (55). 
 
Conclusion 
We have developed a method which provides in a single LC-MALDI-TOF/TOF analysis 
in-depth characterization of partially purified protein complexes: it allows identifying genuine 
partners of the bait, detecting variations in complex composition, as well as pointing to 
phosphorylation sites and estimating their stoichiometry. As illustrated on the Chico samples, this 
method should allow deciphering the functioning of protein modules regulated by dynamical 
phosphorylations and protein associations. This method could be transposed to different enzymes 
to characterize other modifications than phosphorylations, such as N-Acetyl-beta-D-
glucosaminidase to study O-linked N-acetylglucosamine, which can also modulate protein 
association.   
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Figure legends  
 
Figure 1: (a) Protocol developed to characterize partially purified protein complexes in terms of 
phosphorylation sites and stoichiometry. Label P stands for a phosphorylation site. (b) Expected 
patterns of iTRAQ reporter groups in the MS/MS spectra of peptides produced by the protocol of 
Figure 1a. (A) peptides of the proteins initially non-phosphorylated, (B) phosphorylated peptides 
and (C) peptides de-phosphorylated by phosphatases. 
 
Figure 2: (a) Global protocol allowing comparison of protein components and their 
phosphorylations between two different samples. (b) Expected iTRAQ reporter group patterns 
during LC-MS/MS analysis of the previous sample.  
 
Figure 3: MALDI-TOF/TOF MS/MS spectra of (a) angiotensin II and (b) phosphorylated 
angiotensin II obtained when analyzing 300 fmol of a mixture A/pA 40/60, submitted to the 
treatment of Figure 1a. The spectra are interpreted in terms of b-type fragment ions. (c) Plot of 
the experimentally determined level of phosphorylation of angiotensin II in the mixtures A/pA, 
versus the expected level of phosphorylation. Bars indicate the standard deviations calculated on 
the phosphorylation level x, from five measurements of the ratio r obtained from five MS/MS 
spectra of angiotension, and one measurement of the yield of phosphatase treatment in the 
MS/MS spectrum of phosphorylated angiotensin. 
 
Figure 4: Distribution of iTRAQ ratios A(115)/A(114) and A(117)/A(116) measured for peptides 
identified in the TAP sample. Arrows indicate the measurement appearing as an outlier from the 
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main distribution of ratios, which corresponds to peptide AIPAPHEILTSNVVTR from Kin28. A 
zoom leaving aside part of the main distribution is given to highlight the outliers. 
 
Figure 5: MS/MS spectra acquired on peptide LKDAVPFTPFDGDR from Tfb3, known to be 
phosphorylated at Thr8 in the intact protein. (a) Fragmentation of the de-phosphorylated species 
in spot 116, and (b) of the phosphorylated species in spot 112. The whole raw spectrum, a zoom 
on the iTRAQ reporter group region and the interpreted spectrum are successively given. These 
spectra were obtained in the first LC-MALDI-TOF/TOF analysis of the TAP sample.  
 
Figure 6: MS/MS spectra acquired on peptide LVHSISSEDYTQIK from the protein Chico, in 
sample Chico2. Fragmentation (a) of the de-phosphorylated peptide, and (b) of the 
phosphorylated counterpart.  
 
Figure 7: Phosphopeptides (underlined) identified in Chico in the analysis of samples Chico3 
and Chico4. A color code is used to indicate the effect of insulin on the stoichiometry of 
phosphorylation. Red: PO4 induced by insulin, yellow: PO4 increased by insulin, green: PO4 
unaffected by insulin, blue: PO4 decreased by insulin, black: no quantitative information.
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Tables 
 
Peptide 
Spots 
dP/P 
r(115/114) r(117/116) y(115/114) y(117/116) 
x(115/114) 
(%) 
x(117/116) 
(%) 
Kin28, run 1 99/98 3.14 2.19 0.21 0.20 91 86 
Kin28, run 2 91/89 7.44 infinity 0.24 0.37 96 100 
Tfb3, run 1 116/112 31.5 infinity 0.71 0.25 98 100 
Tfb3, run 2 108/103 23.6 infinity 0.56 0.51 98 100 
 
Table 1: Characterization of phosphorylated peptides in the complex involving TAP-Kin28. 
Samples were analyzed twice by LC-MALDI-TOF/TOF (run 1 and run 2). Two phosphopeptides 
were identified, from proteins Kin28 and Tfb3. The iTRAQ ratios A(115)/A(114) and 
A(117)/A(116) were measured in the MS/MS spectra acquired on the non-modified and 
phosphorylated species, leading respectively to the measurement of r and y, which provided 
estimation of the initial phosphorylation levels in the proteins, noted x. Values of r and y 
corrected for inaccurate splitting of the peptide sample are given here. 
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<x> ± SD 
(%) Proteins Peptides sequences 
CIP-SAP lambda 
K.VPQLEIVPNS*AEER.L 75±7 78±7 
K.YKVPQLEIVPNS*AEER.L 87±5 73±22 
K.DIGS*ES*TEDQAMEDIK.Q 74±3 67±15 
Alpha-s1 
casein 
QMEAES*IS*S*S*EEIVPNSVEQK 93±3 84±7 
R.EQLS*TS*EENSKK.T 86±1 82±7 Alpha-s2 
casein R.NANEEEYSIGS*S*S*EES*AEVATEEVK.I 97±4 93±1 
K.IEKFQS*EEQQQTEDELQDK.I 92±2 95±1 
K.FQS*EEQQQTEDELQDK.I 89±2 89±4 
R.ELEELNVPGEIVES*LS*S*S*EESITR.I 91±4 90±2 
Beta-casein 
A.RELEELNVPGEIVES*LS*S*S*EESITR.I 99±1 100±1 
 
Table 2: Study of de-phosphorylated peptides of caseins. Caseins were treated with the protocol 
of Figure 1a, using either CIP and SAP, or lambda phosphatase. Peptides known to bear 
phosphorylations were fragmented in their de-phosphorylated form, to estimate phosphorylation 
levels in the proteins, considering y = 1. An underestimated value of phosphorylation level is 
then obtained. Averages over three MS/MS spectra are given with SD. 
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Protein Acc. 
Number 
Sample Chico1 N(pept) Sample Chico2 N(pept) 
Insulin receptor 
substrate 1 (Chico) 
Q9XTN2 0.10 ± 0.09 45 0.08 ± 0.05 45 
14-3-3 zeta P29310 0.14 ± 0.10 10 0.13 ± 0.11 8 
14-3-3 epsilon P92177 0.15 ± 0.08 10 0.11 ± 0.07 9 
Insulin-like receptor 
precursor 
P09208 0.31 ± 0.14 8 0.27 ± 0.01 2 
CG9354-PA Q9VHE5 / / 0.38 ± 0.05 4 
60 kDa heat shock 
protein, mitochondrial 
O02649 0.48 ± 0.07 4 / / 
Heat shock 70 kDa 
protein cognate 4 
P11147 0.53 ± 0.07 22 0.45 ± 0.08 17 
Heat shock 70 kDa 
protein cognate 3 
P29844 0.56 ± 0.08 11 0.52 ± 0.22 4 
Elongation factor 1-
alpha 
P05303 0.62 ± 0.03 3 0.45 ± 0.09 5 
ADP,ATP carrier 
protein 
Q26365 0.63 ± 0.12 3 / / 
Tubulin alpha-3 chain P06605 0.65 ± 0.15 6 / / 
Tubulin beta-1 chain Q24560 0.67 ± 0.19 10 0.46 ± 0.09 10 
Peroxiredoxin 1 Q9V3P0 0.68 ± 0.19 3 0.41 ± 0.12 4 
Peptidyl-prolyl cis-
trans isomerase 
P25007 0.70 ± 0.12 4 0.38 1 
Heat shock protein 83 P02828 0.77 ± 0.11 5 / / 
CG2331-PA Q9V3C3 0.77 ± 0.18 4 / / 
60S ribosomal protein 
L28 
Q9VZS5 0.81 1 0.52 ± 0.08 10 
60S ribosomal protein 
L14 
P55841 0.83 1 0.34 ± 0.10 5 
Actin-42A P02572 0.85 ± 0.15 9 0.53 ± 0.02 2 
CG8258-PA Q9V4Z4 0.96 ± 0.35 4 / / 
CG11700-PA Q9W417 0.98 ± 0.23 3 / / 
CG30498-PA Q9V4N7 1.30 ± 0.22 12 1.45 ± 0.19 11 
CG3008-PA Q9VR42 1.78 ± 0.51 8 1.26 ± 0.37 4 
 
Table 3: Proteins identified and quantified in samples Chico1 and Chico2. They are organized by 
increasing control/Chico ratio in sample Chico1. 
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Peptide Sample r1 r2 r3 y x1 x2 x3 <x>123 
(%) 
Chico1 1.71 1.28 1.41 / 0.48 0.27 0.35 37±11 LVHSISSEDYTQIK 
(MH = 1908.03 Da) Chico2 1.92 1.73 1.90 0.76 0.55 0.49 0.54 53±3 
Chico1 1.28 1.27 1.18 0.47 0.37 0.36 0.28 34±5 STSAPLLSLK 
(MH = 1304.80 Da) Chico2 1.57 1.55 1.61 0.65
 
0.47 0.46 0.48 47±1 
 
Table 4: Characterization of two phosphorylation sites in samples Chico1 and Chico2. Three 
MS/MS spectra were acquired on the non-modified species LVHSISSEDYTQIK and STSAPLLSLK, 
to determine their iTRAQ ratios ri. The phosphorylated counterparts were searched in 
neighboring MALDI spots and also fragmented, to estimate the yield of phosphatase treatment, y, 
and localize phosphorylations. The table provides r and y values corrected for inaccurate 
splitting of the peptide sample into two halves. The initial levels of phosphorylation, xi, were 
estimated from the three values ri and from y. The intact phospho-form of peptide 
LVHSISSEDYTQIK could not be detected in sample Chico1; then the value of y measured in 
Chico2 was taken into account to calculate x. The average estimation of x and the corresponding 
standard deviation are finally given. 
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Chico3  
(%) 
Chico4  
(%) 
Peptide 
MH of 
phosphopeptide 
(Da) 
Residue 
14-3-
3 
bind? 
Mascot 
score 
+INS noINS +INS noINS 
SCS*SPHNYGFGR 
1581.64 
S284 or 
S286 
bind 1 35 
49±7 None None 47±2 
CDS*LPTR 1061.46 S300 bind 1 / 76±10 10±13 62±10 none 
(SSS)*ANEASKPINVNVIQNSQNSLELR 3167.63 S258-260 bind 2 38 76±2 26±19 94±1 78±3 
STS*APLLSLK 
1384.80 
T554 or 
S555 
bind 2 32 
77±2 56±4 68±5 59±4 
KSTS*APLLSLK 1657.00 T554/S555 bind 2 24 83±2 65±4 ND ND 
A(YSVGS)*K 1079.57 res 500-506 bind 2 / >71±5 >33±11 ND ND 
AYS*IGNK 
1120.60 
Y470 or 
S471 
/ 35 
76±3 53±10 ND ND 
AYS*IGNKVEHLK 
1871.05 
Y470 or 
S471 
/ 38 
89±2 48±12 84±1 58±10 
LVHSIS*SEDYTQIK 1988.03 S784 / 13 NTW NTW 27±8 69±5 
KLVHSIS*SEDYTQIK 2260.23 S784 / 68 43±4 53±4 38±5 58±5 
ILQIKS*DSSLISSK 2031.18 S813-S819 / 33 90±3 93±1 ND ND 
HSNS*PTFTMPLR 
1611.74 
S340 or 
S342 
/ 61 
NTY NTY 62±2 65±4 
I(SQPELHYASLDLPHCS)*GQNPAK 2919.41 Pept 904-926 / / 36±20 82±8 None 91±3 
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NG(TLSESSNQT)*YFGSNHGLR 2393.10 T307-S312 / 32 Pbm Pbm Pbm Pbm 
GSRES*PPVSACPEDGNTYAK 
2479.05 
S932 or 
S935 
/ 32 
NQ NQ NQ NQ 
ES*PPVSACPEDGNTYAK 2178.97 S935 / 22 NQ NQ NQ NQ 
 
Table 5: Characterization of phosphorylated peptides detected in the protein Chico, purified from cells stimulated (+INS) or not 
stimulated (noINS) by insulin. Mascot scores are indicated when the phosphopeptide was identified by database search, by taking into 
account possible phosphorylation at S,T,Y. Some identified tryptic peptides appear to overlap (underlined below) with 14-3-3-binding 
sequences predicted by Scansite: SLELRSCS*SPHNYGF, FGRERCDS*LPTRNGT (both predicted by a high-stringency search); 
PMRKRSSS*ANEASKP, NRQKKSTS*APLLSLK, PNRVRAYS*VGSKSKI and HEPMRKRS*SSANEAS (further predicted by a 
medium-stringency search). ‘None’: no phosphorylation could be detected due to iTRAQ ratios below 1 measured on the de-
phosphorylated species. ‘ND’: the peptide was not detected. ‘NT’: quantification not trusted; NTW: the obtained spectrum was too 
Weak to allow identification and/or reliable quantification; NTY: the Yield of de-phosphorylation was too low to obtain a reliable 
estimate of the initial phosphorylation level. For peptide AYSVGSK, an under-estimation of the initial phosphorylation level is 
calculated because the intact phospho-species could not be fragmented, therefore the yield of phosphatase treatment could not be 
measured. ‘Pbm’: the peptide was fragmented in two well separated MALDI spots, maybe due to two different conformations, and 
provided two contradictory values for iTRAQ ratios A(115)/A(114) on the one hand and A(117)/A(116) on the other hand. NQ: not 
quantified, see discussion and supplementary data 3 for this specific case.  
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Protein Acc. 
Number 
Sample 
Chico3 
N(pept) Sample 
Chico4 
N(pept) 
Insulin receptor 
substrate 1 (Chico) 
Q9XTN2 1.00 ± 0.18 32 1.00 ± 0.22 34 
14-3-3 zeta P29310 0.41 ± 0.11 12 0.89 ± 0.14 10 
14-3-3 epsilon P92177 0.51 ± 0.13 18 0.84 ± 0.13 17 
Insulin-like receptor 
precursor 
P09208 0.76 ± 0.18 12 0.80 ± 0.11 5 
60 kDa heat shock 
protein, 
mitochondrial 
O02649 0.98 ± 0.14 6 1.34 ± 0.09 6 
Heat shock 70 kDa 
protein cognate 4 
P11147 0.97 ± 0.14 19 1.35 ± 0.21 13 
Heat shock 70 kDa 
protein cognate 3 
P29844 0.86 1 1.09 ± 0.10 7 
Elongation factor 1-
alpha 
P05303 0.69 ± 0.08 5 1.28 ± 0.18 5 
Tubulin alpha-3 
chain 
P06605 1.27 ± 0.23 3 1.18 ± 0.10 5 
Tubulin beta-1 chain Q24560 0.99 ± 0.12 6 1.20 ± 0.12 9 
60S ribosomal 
protein L13 
P41126 1.00 ± 0.07 3 / / 
Actin-42A P02572 1.17 ± 0.33 6 0.81 ± 0.01 3 
Pterin-4-alpha-
carbinolamine 
dehydratase 
O76454 0.54 ± 0.08 7 1.46 ± 0.07 4 
Probable prefoldin 
subunit 2 
Q9VTE5 0.74 ± 0.04 3 1.14 ± 0.15 4 
Probable prefoldin 
subunit 3 
Q9VGP6 / / 1.29 ± 0.10 4 
Probable prefoldin 
subunit 5 
Q9VCZ8 / / 1.04 ± 0.15 4 
CG14816-PA O46084 / / 1.12 ± 0.22 3 
CG6815-PA Q9VEX6 / / 1.45 ± 0.15 4 
CG31918-PA Q9VMU6 / / 1.92 ± 0.35 4 
 
Table 6: Proteins quantified in samples Chico3 and Chico4. 
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Figures  
Figure 1a 
 
 
 
 
 
 
Figure 1b 
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Figure 2a 
 
 
 
 
 
Figure 2b 
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Figure 3 
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Figure 4 
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Figure 5a 
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Figure 5b 
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Figure 6a 
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Figure 6b 
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Figure 7 
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